Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2026-02-20 @ 10:09 PM
Study NCT ID:
NCT00095693
Status:
TERMINATED
Last Update Posted:
2014-01-16
First Post:
2004-11-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Anaplastic Thyroid Cancer | View |
| None | Insular Thyroid Cancer | View |
| None | Recurrent Thyroid Cancer | View |
| None | Stage III Follicular Thyroid Cancer | View |
| None | Stage III Papillary Thyroid Cancer | View |
| None | Stage IV Follicular Thyroid Cancer | View |
| None | Stage IV Papillary Thyroid Cancer | View |
Keywords: